Steroid therapy reduces mesangial matrix accumulation in advanced IgA nephropathy

Nephrol Dial Transplant. 2003 Jul;18(7):1311-5. doi: 10.1093/ndt/gfg135.

Abstract

Background: Steroid therapy for IgA nephropathy (IgAN) has been reported to ameliorate the long-term prognosis of IgAN, but its mode of action has not been fully elucidated. In this study, we examined the effect of steroids on glomerular morphological changes in IgAN.

Methods: We examined 16 patients with biopsy-proven IgAN (male/female =11/5, mean age 32.1 years) who were divided into prognosis groups according to criteria set by the Japanese Society of Nephrology. Initially, they received a loading dose of steroids, followed by a daily dose of 10-15 mg prednisolone. After 12 months, they underwent a second biopsy, and their histological and clinical features were examined.

Results: Before and after therapy, systolic blood pressure, diastolic blood pressure, serum creatinine and creatinine clearance all remained unchanged. However, urinary protein excretion decreased dramatically, from 1.6+/-1.7 to 0.4+/-0.2 g/day (P<0.005). Furthermore, computerized imaging revealed a significant reduction of the mesangial matrix index (MMI) from 14.5+/-5.2 to 9.5+/-3.6% (P<0.001). The numbers of sclerosing glomeruli did not change.

Conclusions: Steroid therapy reduces mesangial matrix accumulation and reduces urinary protein excretion in advanced IgAN.

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / pharmacology*
  • Anti-Inflammatory Agents / therapeutic use*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Extracellular Matrix / drug effects*
  • Extracellular Matrix / pathology*
  • Female
  • Follow-Up Studies
  • Glomerular Mesangium / drug effects*
  • Glomerular Mesangium / pathology*
  • Glomerulonephritis, IGA / drug therapy*
  • Glomerulonephritis, IGA / pathology*
  • Glomerulonephritis, IGA / urine
  • Humans
  • Image Interpretation, Computer-Assisted
  • Male
  • Methylprednisolone / administration & dosage
  • Methylprednisolone / pharmacology*
  • Methylprednisolone / therapeutic use*
  • Middle Aged
  • Prednisolone / administration & dosage
  • Prednisolone / pharmacology*
  • Prednisolone / therapeutic use*
  • Prognosis
  • Severity of Illness Index
  • Time Factors

Substances

  • Anti-Inflammatory Agents
  • Prednisolone
  • Methylprednisolone